- In-home trial delivery makes participation easier, more convenient and more accessible
- Increasing trial access to more patients by empowering and supporting a variety of community research sites
- How trial design can deliver increased recruitment and retention in a cost-effective way
- Trends observed during the JP Morgan Healthcare conference
- The impact of the new administration on clinical trials
- How independent adjudication improves endpoint accuracy and consistency in trials.
- Ways adjudication improves data accuracy and regulatory compliance.
- Strategies to reduce risk and streamline trial timelines.
- How to reduce variability and disputes in clinical endpoint assessments.
- Evolution of CRO FSP models
- Balancing growth and quality in a hybrid model
- The future of scaling and offshore integration
- Prioritizing your organizational structure and goals
- Key considerations for developing a bespoke outsourcing framework
- Building resilient outsourcing strategies that align with future clinical development needs
- How to create a patient-centric clinical protocol to obtain the necessary data and validate your primary objective
- How biotechs are using tools internally and managing different stakeholders to pressure test themselves to have less complicated protocols
- Looking at ways to ensure patients don’t go through a burdensome process
- Championing collaborative sites for a streamlined trial
- Understanding UDI requirements across regions
- Implementing UDI systems for traceability and safety
- Leveraging UDI data for operational efficiency
- Automating Adverse Event Evaluations: Enhancing speed and accuracy using AI.
- Streamlining Clinical Protocol Training: Efficiently generating consistent training materials with AI.
- Improving Medical Coding: Utilizing AI for accurate adverse event classification and regulatory compliance.
- Reducing cycle times and operational costs and enhancing data accuracy to
better clinical trial results
